Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.46 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.45 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.44 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.44 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.44 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | NT5E | P21589 | 3/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 6/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 6/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 6/20 | 0.42 |
| ▸ | ADORA2B | P29275 | 5/20 | 0.42 |
| ▸ | HINT1 | P49773 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26808383 | 1.00 | ACHE (0.46) | ACHEP2RY11SLC29A1P2RX3P2RX4 | |
| SCHEMBL17464581 | 0.88 | P2RY11 (0.48) | ACHEP2RY11SLC29A1P2RX3P2RX4 | |
| SCHEMBL26808476 | 0.88 | P2RY11 (0.48) | ACHEP2RY11SLC29A1P2RX3P2RX4 | |
| SCHEMBL15837358 | 0.88 | P2RY11 (0.48) | ACHEP2RY11SLC29A1P2RX3P2RX4 | |
| SCHEMBL26808564 | 0.86 | ACHE (0.45) | ACHEP2RY11SLC29A1P2RX3P2RX4 | |
| SCHEMBL26808390 | 0.86 | HINT1 (0.52) | P2RY11P2RX3P2RX4P2RX2NT5E | |
| SCHEMBL26808255 | 0.86 | HINT1 (0.52) | P2RY11P2RX3P2RX4P2RX2NT5E | |
| SCHEMBL26808333 | 0.85 | P2RX3 (0.60) | P2RY11P2RX3P2RX4P2RX2NT5E | |
| SCHEMBL6761729 | 0.81 | LMNA (0.58) | ACHEP2RY11P2RX3P2RX4P2RX2 | |
| SCHEMBL6761727 | 0.81 | LMNA (0.58) | ACHEP2RY11P2RX3P2RX4P2RX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357306-A1 | SYNTHESIS OF 1,2,5-TRI-O-BENZOYL-3-DIBENZYLAMINO-3-DEOXYRIBOSE AS INTERMEDIATE FOR PRODUCING 3'-AMINO-3'-DEOXYADENOSINE AND 3'-AMINO-3'-DEOXYGUANOSINE AND THE PROTECTED DERIVATIVES THEREOF | BRISTOL MYERS SQUIBB CO (US) | 2023-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357306-A1 | SYNTHESIS OF 1,2,5-TRI-O-BENZOYL-3-DIBENZYLAMINO-3-DEOXYRIBOSE AS INTERMEDIATE FOR PRODUCING 3'-AMINO-3'-DEOXYADENOSINE AND 3'-AMINO-3'-DEOXYGUANOSINE AND THE PROTECTED DERIVATIVES THEREOF | STING1, CGAS, AMPD3 | ACHE 4104/4885P2RY11 175/4885SLC29A1 468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.